A Phase II Randomized, Double Blind, Parallel Group Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine
Condition: Rotavirus Infections Interventions: Biological: RV3-BB; Biological: Placebo Sponsor: Murdoch Childrens Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2018 Category: Research Source Type: clinical trials
